166 filings
Page 3 of 9
6-K
3b5lz8m gyzkcs2v5
28 Feb 23
Current report (foreign)
4:10pm
6-K
a4wzb4pqbcyctf6uc7
30 Jan 23
Current report (foreign)
4:10pm
6-K
llm tyehlaff
24 Jan 23
GENFIT Announces 2023 Financial Calendar
4:10pm
6-K
ef5knv68 rntdlqaj9b6
5 Jan 23
GENFIT to Participate in Upcoming Investor Conferences
4:10pm
6-K
ifmlvyt7066u5umx
17 Nov 22
GENFIT Pipeline Day Highlights Diverse Product Portfolio in Underserved Liver Diseases
4:10pm
6-K
mu0om
10 Nov 22
GENFIT Reports Third Quarter 2022 Financial Information
4:10pm
6-K
nuh6mlywyz 8y7m
25 Oct 22
Current report (foreign)
4:10pm
6-K
mg04wn 9urxyscdk
29 Sep 22
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
4:10pm
6-K
gm5aj
28 Sep 22
GENFITÂ Reports First Half-Year 2022 Financial Results and Provides Corporate Update
4:13pm
6-K
okpj18
19 Sep 22
GENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseases
6:10am
6-K
k8c7ckwcc pc3s57mis
13 Sep 22
FDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinoma
4:15pm
6-K
4xwr7hygv
8 Jul 22
Current report (foreign)
4:15pm
6-K
ic8d6cw
25 May 22
Current report (foreign)
4:10pm
6-K
wqyxldju1qerhfy1
11 May 22
GENFIT Reports First Quarter 2022 Financial Information
4:10pm
6-K
aaudovwa2pp0tpml ub
29 Apr 22
GENFIT Announces Publication of the 2021 Universal
4:10pm
6-K
szzp6o8yuqcsn
27 Apr 22
Shareholders' and Unitholders' Meetings
9:43am
6-K
ook qlersq3
20 Apr 22
Current report (foreign)
4:10pm
6-K
ut4vzqoj 2d
7 Apr 22
GENFIT Reports Full-Year 2021 Financial Results and Provides Corporate Update
4:10pm
6-K
qb6u u4hla9bvuudp38
1 Mar 22
Current report (foreign)
6:08am